Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NSCLC, Stage II”

2,487 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,487 results

Testing effectiveness (Phase 2)Study completedNCT01262560
What this trial is testing

Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer

Who this might be right for
DysphagiaLung CancerPain+1 more
Radiation Therapy Oncology Group 163
Testing effectiveness (Phase 2)Looking for participantsNCT05789082
What this trial is testing

A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 320
Testing effectiveness (Phase 2)Study completedNCT03102242
What this trial is testing

Atezolizumab Immunotherapy in Patients With Advanced NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Alliance Foundation Trials, LLC. 64
Early research (Phase 1)Ended earlyNCT02252796
What this trial is testing

Phase I Hypofractionated Stereotactic Boost (Radiotherapy) for Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
West Virginia University 1
Testing effectiveness (Phase 2)UnknownNCT00104780
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Epimmune
Testing effectiveness (Phase 2)Ended earlyNCT03148327
What this trial is testing

Astra Zeneca (Immuno Stereotactic Ablative Body Radiotherapy) ISABR Study: Randomized Phase I/II Study of Stereotactic Body Radiotherapy

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Jonsson Comprehensive Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT00305786
What this trial is testing

Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Miami 30
Not applicableWithdrawnNCT00880386
What this trial is testing

Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer

Who this might be right for
DyspneaLung CancerPulmonary Complications+1 more
University of South Florida
Testing effectiveness (Phase 2)WithdrawnNCT05815186
What this trial is testing

Ladarixin With Sotorasib in Advanced NSCLC - Phase II

Who this might be right for
Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
NYU Langone Health
Testing effectiveness (Phase 2)Study completedNCT00459342
What this trial is testing

Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung CancerRecurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer+1 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT00887783
What this trial is testing

Navelbine And Radiotherapy in Locally Advanced Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Odense University Hospital 117
Testing effectiveness (Phase 2)Looking for participantsNCT07323641
What this trial is testing

Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell Carcinoma
Jonsson Comprehensive Cancer Center 60
Early research (Phase 1)Study completedNCT02225405
What this trial is testing

Cisplatin, Docetaxel, and Nintedanib Before Surgery in Treating Patients With Previously Untreated Stage IB-IIIA Non-small Cell Lung Cancer

Who this might be right for
Stage IB Non-Small Cell Lung Carcinoma AJCC v7Stage II Non-Small Cell Lung Cancer AJCC v7Stage IIA Non-Small Cell Lung Carcinoma AJCC v7+2 more
M.D. Anderson Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00405951
What this trial is testing

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)in Combination With Docetaxel for the Treatment of Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Gemin X 47
Testing effectiveness (Phase 2)Looking for participantsNCT06467500
What this trial is testing

A Prospective, Open-label, Single-center, Single-arm Phase II Clinical Study of Cadonilimab (AK104) Combined With Monotherapy Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer With Negative Driver Genes and Failed Immunotherapy

Who this might be right for
Non-small Cell Lung Cancer
Xin-Hua Xu 48
Testing effectiveness (Phase 2)UnknownNCT01980472
What this trial is testing

Chemotherapy Plus Bevacizumab in Elderly Non-small Cell Lung Cancer Patients

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Grupo de Investigación y Divulgación Oncológica 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04958811
What this trial is testing

Tiragolumab With Atezolizumab Plus Bevacizumab in Previously-Treated Advanced Non-squamous NSCLC

Who this might be right for
Non-squamous Non-small-cell Lung Cancer
Georgetown University 29
Large-scale testing (Phase 3)UnknownNCT04968002
What this trial is testing

Application of Pablizumab Combined With Apatinib and Chemotherapy in Resectable Non-small Cell Lung Cancer： A Prospective, Single Arm, Single Center Phase II Clinical Study of Neoadjuvant Therapy

Who this might be right for
Non-small Cell Lung Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 40
Testing effectiveness (Phase 2)Study completedNCT03977467
What this trial is testing

Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 Inhibitor

Who this might be right for
Non-Small Cell Lung CancerSolid Tumor
SCRI Development Innovations, LLC 46
Testing effectiveness (Phase 2)Study completedNCT00081107
What this trial is testing

Epothilone D in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Platinum-Based Chemotherapy

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center
Next Page